达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DVA 达维塔保健

交易中 11-06 15:42:17 EST

191.28

-3.54

-1.82%

最高191.90	最低188.80	成交量30.54万
今开190.08	昨收194.82	日振幅1.59%
总市值120.32亿	流通市值63.21亿	总股本6,290万
成交额5,811万	换手率0.92%	流通股本3,304万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DVA","market":"US","secType":"STK","nameCN":"达维塔保健","latestPrice":191.28,"timestamp":1793997732029,"preClose":194.82,"halted":0,"volume":305360,"delay":0,"changeRate":-0.018170619032953455,"floatShares":33044200,"shares":62900000,"eps":13.549191,"marketStatus":"交易中","change":-3.54,"latestTime":"11-06 15:42:17 EST","open":190.0788,"high":191.8999,"low":188.8,"amount":58105684.102400005,"amplitude":0.015912,"askPrice":191.25,"askSize":93,"bidPrice":191.1,"bidSize":60,"shortable":3,"etf":0,"ttmEps":13.549191,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1793998800000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":815029200000,"exchange":"NYSE","adjPreClose":194.82,"preHourTrading":{"tag":"盘前","latestPrice":192.8,"preClose":194.82,"latestTime":"09:14 EST","volume":44,"amount":8496.4396,"timestamp":1793974482616,"change":-2.02,"changeRate":-0.010369,"amplitude":0.021866},"postHourTrading":{"tag":"盘后","latestPrice":194.82,"preClose":194.82,"latestTime":"19:45 EST","volume":21262,"amount":4142404.9289,"timestamp":1793925908400,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.307514,"impliedVol":0.3873,"impliedVolPercentile":0.4382},"requestUrl":"/m/hq/s/DVA","defaultTab":"news","newsList":[{"id":"1111472543","title":"异动解读｜达维塔保健盘中上涨5.08%，瑞银上调目标价至287美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111472543","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111472543?lang=zh_cn&edition=full","pubTime":"2026-11-05 00:49","pubTimestamp":1793810956,"startTime":"0","endTime":"0","summary":"11月5日，达维塔保健盘中上涨5.08%，报191.43美元，成交额5245.96万美元。消息面上，瑞银最新将达维塔保健目标价由270美元上调至287美元，并维持买入评级，成为本次股价异动的直接催化。此前公司第三季度调整后每股收益3.82美元、营收35.78亿美元，均高于市场预期，并将全年调整后每股收益指引下限由14.10美元上调至14.30美元。相较之下，巴克莱日前将目标价从224美元下调至216美元，显示机构分歧仍在，但最新上调评级信息对短线情绪形成更强支撑。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健获瑞银上调目标价，盘中应声上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185994340","title":"异动解读｜达维塔保健盘中下跌5.61%，财报超预期但全年指引上调有限","url":"https://stock-news.laohu8.com/highlight/detail?id=1185994340","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185994340?lang=zh_cn&edition=full","pubTime":"2026-10-30 21:58","pubTimestamp":1793368736,"startTime":"0","endTime":"0","summary":"10月30日，达维塔保健盘中下跌5.61%，报179.54美元/股，成交额7313.51万美元。此次异动主要由最新财报及指引共同驱动。公司第三季度调整后每股收益为3.82美元，高于市场预期的3.57至3.61美元；营收为35.8亿美元，也高于预期的35.08至35.2亿美元。不过，公司仅将全年调整后每股收益指引由14.10至15.20美元上调至14.30至15.20美元，区间上限维持不变，低于市场预期的14.82美元；同时，巴克莱将目标价下调至216美元，均对股价形成压制。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健财报超预期，但指引上调有限","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193964956","title":"异动解读｜达维塔保健盘前下跌6.63%，财报超预期但全年指引上调有限","url":"https://stock-news.laohu8.com/highlight/detail?id=1193964956","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193964956?lang=zh_cn&edition=full","pubTime":"2026-10-30 20:26","pubTimestamp":1793363219,"startTime":"0","endTime":"0","summary":"10月30日，达维塔保健盘前下跌6.63%，报181.875美元/股，成交额17.37万美元。本次异动主要由最新财报与全年指引共同驱动。公司第三季度调整后每股收益为3.82美元，高于市场预期的3.57至3.61美元；营收为35.8亿美元，也高于预期的35.08至35.2亿美元。不过，公司仅将全年调整后每股收益指引由14.10至15.20美元上调至14.30至15.20美元，区间上限维持不变，市场预期为14.82美元，指引提升幅度偏温和，压制了股价表现。此外，公司还披露从伯克希尔哈撒韦回购382563股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健盘前下跌，全年指引上调有限","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195376019","title":"异动解读｜达维塔保健夜盘下跌8.94%，财报超预期但指引上调幅度有限","url":"https://stock-news.laohu8.com/highlight/detail?id=1195376019","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1195376019?lang=zh_cn&edition=full","pubTime":"2026-10-30 08:05","pubTimestamp":1793318737,"startTime":"0","endTime":"0","summary":"10月30日，达维塔保健夜盘下跌8.94%，报176.02美元/股，成交额176.0美元。本次异动主要由财报消息驱动。公司第三季度调整后每股收益3.82美元，高于市场预期的3.57美元至3.61美元；营收35.8亿美元，也高于预期的35.2亿美元至35.08亿美元。不过，全年调整后每股收益指引仅由14.10至15.20美元上调至14.30至15.20美元，区间上限未变，市场预期为14.82美元。尽管业绩超预期，但指引提升力度偏温和，夜盘股价因此承压。另有披露显示，公司从伯克希尔哈撒韦回购382563股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健夜盘下跌，业绩指引上调温和","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679423229","title":"SEC文件显示，DaVita从伯克希尔哈撒韦(BRK.A.N、BRK.B.N)回购382,563股，回购后伯克希尔仍持有","url":"https://stock-news.laohu8.com/highlight/detail?id=2679423229","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679423229?lang=zh_cn&edition=full","pubTime":"2026-10-30 05:35","pubTimestamp":1793309759,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4196","DVA","BK4588","BK4559","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192453199","title":"异动解读｜达维塔保健盘后下跌8.78%，财报虽超预期但市场反应承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1192453199","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1192453199?lang=zh_cn&edition=full","pubTime":"2026-10-30 04:21","pubTimestamp":1793305275,"startTime":"0","endTime":"0","summary":"10月30日，达维塔保健盘后下跌8.78%，报175.0美元/股，成交额432.37万美元。本次异动发生在财报发布后，属于典型财报驱动。达维塔保健 Inc.是一家领先的医疗保健供应商，专注于转变护理提供方式，以提高全球患者的生活质量。达维塔保健对创新和综合护理的承诺旨在改善结果，同时最大限度地降低成本，从而加强其作为值得信赖的提供者和合作伙伴在医疗保健领域的地位。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健财报超预期，盘后却承压下跌","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1149588478","title":"异动解读｜达维塔保健盘中上涨5.15%，财报前市场看好营收与EPS韧性","url":"https://stock-news.laohu8.com/highlight/detail?id=1149588478","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1149588478?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:55","pubTimestamp":1793285712,"startTime":"0","endTime":"0","summary":"10月29日，达维塔保健盘中上涨5.15%，报193.41美元/股，成交额8212.47万美元。消息面上，公司将于当日发布最新季度财报，市场一致预期本季度营收35.08亿美元，同比增长2.31%；调整后每股收益3.61美元，同比增长11.90%，显示营收小幅增长、EPS韧性较强。此前公司二季度调整后每股收益4.02美元、营收35.54亿美元，均高于市场预期；同时，公司与Humana在慢性肾病管理上的价值导向合作于7月启动，也强化了其中长期业务拓展预期。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健财报前上涨，市场看好营收与EPS韧性","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128469987","title":"异动解读｜达维塔保健盘中上涨5.16%，财报前景偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1128469987","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128469987?lang=zh_cn&edition=full","pubTime":"2026-10-23 03:43","pubTimestamp":1792698185,"startTime":"0","endTime":"0","summary":"10月23日，达维塔保健盘中上涨5.16%，报185.86美元/股，成交额9676.94万美元。消息面上，公司将于10月29日发布新一季财报，市场预期本季度营收35.08亿美元，同比增2.31%，调整后每股收益3.61美元，同比增11.90%，整体呈现营收小幅增长、EPS韧性较强的组合。此外，公司上一季度调整后每股收益4.02美元、高于预期的3.88美元，营收35.54亿美元亦超预期。若此次财报显示成本控制好于市场假设，股价仍有正向反应空间。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"达维塔保健盘中上涨，财报预期偏乐观","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138147510","title":"财报前瞻 | 达维塔保健本季度营收预计小幅增长，机构观点偏乐观","url":"https://stock-news.laohu8.com/highlight/detail?id=1138147510","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138147510?lang=zh_cn&edition=full","pubTime":"2026-10-22 11:45","pubTimestamp":1792640702,"startTime":"0","endTime":"0","summary":"达维塔保健将在2026年10月29日发布最新季度财报，市场关注营收与EPS延续韧性表现、成本与付款环境变化对利润率的影响。市场一致预测达维塔保健本季度总营收为35.08亿美元，同比增加2.31%，EBIT为5.42亿美元，同比预测下降6.05%，调整后每股收益为3.61美元，同比预测增长11.90%。结合上述观点，本季度更可能出现“营收小幅增长、EPS韧性较强”的组合，若财报披露显示成本控制好于市场假设，股价存在正向反应的空间。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报前瞻 | 达维塔保健本季度营收预计小幅增长，机构观点偏乐观","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114068343","title":"异动解读｜达维塔保健盘中下跌5.18%，缺乏明确新催化剂","url":"https://stock-news.laohu8.com/highlight/detail?id=1114068343","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114068343?lang=zh_cn&edition=full","pubTime":"2026-10-21 01:55","pubTimestamp":1792518903,"startTime":"0","endTime":"0","summary":"10月21日，达维塔保健盘中下跌5.18%，报177.32美元/股，成交额2.34亿美元。达维塔保健所在的保健护理服务行业中，西维斯健康上涨1.76%，Hims & Hers Health Inc.上涨5.54%，信诺保险上涨2.49%，Hinge Health, Inc.上涨3.29%，Guardant Health Inc.上涨2.02%。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147703794","title":"美股夜盘 | 美光科技跌1.19%，存储股中率先转涨","url":"https://stock-news.laohu8.com/highlight/detail?id=1147703794","media":"行情速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1147703794?lang=zh_cn&edition=full","pubTime":"2026-10-16 08:10","pubTimestamp":1792109414,"startTime":"0","endTime":"0","summary":"10月16日，美股夜盘时段， $旅行者财产险集团$上涨 1.27%。该股在季度财报公布前走高，分析师预期其营收下滑 1% 至 113.8 亿美元，调整后每股收益 7.42 美元；上一季度公司受益于巨灾损失减少、投资收益强劲，业绩表现亮眼。存储板块波动突出：美光科技股价大幅震荡，盘中一度大跌超 6%，之后率先反弹翻红，最终收跌 1.19%。板块相关标的中， $Roundhill Memory ETF$回落 2.64%， $三倍做多半导体ETF-Direxion Daily$大跌 1.81%","market":"us","thumbnail":"https://static.tigerbbs.com/4f6ec6e99c0c8b9feb7f296b78c65a54","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/4f6ec6e99c0c8b9feb7f296b78c65a54"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNDK","SNXX","SNDU","TRV","DRAM","AMUU","AMDD","AMD","AMDW",".SPX","DAMD","SNDC",".IXIC",".DJI","AMDG","AMYY","AMDC","SOXL","SNDG","AMDL","AMDY","DVA","SNDQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111999012","title":"财报超预期反而成“利空”？华尔街交易逻辑生变：仅仅Beat已经不够","url":"https://stock-news.laohu8.com/highlight/detail?id=1111999012","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1111999012?lang=zh_cn&edition=full","pubTime":"2026-09-27 08:59","pubTimestamp":1790470764,"startTime":"0","endTime":"0","summary":"更值得关注的是，本轮财报季的预期门槛本身并不低。而在财报公布之前，Datadog股价年内已经上涨超过一倍。财报公布次日，英伟达股价上涨8.7%，单日市值增加约4420亿美元。这意味着企业进入下一轮财报季时，面对的不是被提前压低的预期，而是持续上升的盈利门槛。财报Beat只是第一道门槛，真正决定股价表现的，可能是公司能否进一步击败已经计入股价的高预期，并证明未来增长足以支撑当前估值。","market":"us","thumbnail":"https://community-static.tradeup.com/news/d67fb993ad427e6dd8efb2f24563e514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/d67fb993ad427e6dd8efb2f24563e514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"财报超预期反而成“利空”？华尔街交易逻辑生变：仅仅Beat已经不够","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WDCC","DDOG","SNDC","SPUU","DIA","DMAX","HIBL","SPY","SDOW","SPYM","UDOW","SPYH","SNDQ","DVA","WDC","SPDN","SPXL","SNXX","UPRO","DXD","DDM","SSO","SNDU","WDCX",".SPX","MMAX","SDS","SNDK","SPYU","DOG","SPXS","YSPY","SNDG","SPXU","SPYQ","SH","VOO",".IXIC",".DJI","IVV","SMAX"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1139696722","title":"异动解读｜达维塔保健盘中下跌5.12%，报183.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139696722","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139696722?lang=zh_cn&edition=full","pubTime":"2026-09-18 03:27","pubTimestamp":1789673243,"startTime":"0","endTime":"0","summary":"9月17日，达维塔保健盘中下跌5.12%，报183.93美元/股，成交额1.22亿美元。达维塔保健所在的保健护理服务行业中，个股中，西维斯健康跌1.0%，Guardant Health涨4.04%，Hims & Hers Health涨0.29%，信诺保险跌0.85%，奎斯特诊疗涨0.06%。达维塔保健是一家领先的综合性肾脏护理提供商，拥有超过25年经验，提供从减缓肾脏疾病进展到促进移植的全程服务，运营透析中心并支持家庭护理。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196746769","title":"达维塔保健与Humana达成新型价值导向合作，扩大慢性肾病患者的医疗服务范围","url":"https://stock-news.laohu8.com/highlight/detail?id=1196746769","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196746769?lang=zh_cn&edition=full","pubTime":"2026-08-25 18:04","pubTimestamp":1787652251,"startTime":"0","endTime":"0","summary":"达维塔保健（DaVita HealthCare Partners）宣布，与Humana建立一项全新的价值导向型合作伙伴关系，旨在进一步拓展对慢性肾脏病患者的照护版图。此项合作聚焦于以患者为中心的医疗服务模式，力求在提升疗效的同时优化成本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4559","BK4196","BK4588","DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911935","title":"板块普涨之际 十只量化评分强劲的大盘医疗保健股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911935","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658911935?lang=zh_cn&edition=full","pubTime":"2026-08-11 23:27","pubTimestamp":1786462073,"startTime":"0","endTime":"0","summary":"经历 2022-2023年板块低迷后，医疗保健板块在2026年重新积聚上涨动能。Centene Corporation以4.97分接近满分的量化评分位居榜单首位；Corcept Therapeutics、Bright Spring Health Services紧随其后，评分分别为4.93、4.91；Halozyme Therapeutics、Humana跻身前五，均获强烈“买入”评级。即便板块整体处在历史高位，个股之间量化评分分化依旧显著。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"303689","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","LU1548497426.USD","LU0072461881.USD","CORT","IE00BN29S564.USD","IE00B1XK9C88.USD","LU0320765992.SGD","LU0949170772.SGD","IE00BJJMRY28.SGD","LU0289739699.SGD","LU2236285917.USD","LU1069347547.HKD","FBT","BK4581","SG9999002224.SGD","LU0342679015.USD","LU0965509283.SGD","LU1267930573.SGD","LU2468319806.SGD","LU1674673691.USD","LU2112291526.USD","LU0354030438.USD","IE00B2B36J28.USD","LU1854103824.USD","BK4154","LU2271345857.HKD","IE00BFXG1179.USD","LU1559883803.SGD","MHIP","LU2361045086.USD","LU1791710582.SGD","LU2361044865.SGD","LU1064131342.USD","LU0345770308.USD","LU1983299246.USD","LU2462591277.SGD","SG9999002232.USD","IE00BSNM7G36.USD","LU1674673428.USD","LU1934455194.USD","LU0109394709.USD","CNC","LU2552382215.SGD","BK4532","IE00BKVL7J92.USD","IE00BFSS8Q28.SGD","LU0029864427.USD","LU0823416689.USD","LU1720051108.HKD","LU0566484027.USD","SOLV","IHF","LU1267930490.SGD","BK4566","SG9999018857.SGD","CNCG","LU0203347892.USD","SG9999014898.SGD","LU1066051811.HKD","LU0417517546.SGD","LU0795875169.SGD","BTSG","FHLC","FFOX","IE0004445015.USD","LU0861579265.USD","LU0557290698.USD","LU0122379950.USD","LU2065171311.SGD","LU0648001328.SGD","IE00B1BXHZ80.USD","IE00BWXC8680.SGD","LU0976567544.SGD","LU1718418525.SGD","LU0354030511.USD","IYH","LU1732799900.SGD","LU2264538146.SGD","LU2089984988.USD","IE00BFSS7M15.SGD","LU0316494557.USD","LU0672654240.SGD","LU0077335932.USD","IE0005OL40V9.USD","IE00B19Z8W00.USD","LU0211326839.USD","LU2125154778.USD","IE00B775H168.HKD","LU2357627491.SGD","PTH","IE00B7SZLL34.SGD","UNHW","LU0143551892.USD","BK4559","LU0661504455.SGD","LU0820562030.AUD","LU1267930730.SGD","PSCH","LU0943347566.SGD","LU1057294990.SGD","LU2491049909.HKD","LU0310799852.SGD","RXL","LU1291159041.SGD","IE00BJJMRX11.SGD","LU1261432733.SGD","LU1989771016.USD","LU1506573853.SGD","LU0114720955.EUR","LU0889565916.HKD","LU0070302665.USD","BK4613","IXJ","BK4533","LGHT","LU2089283258.USD","LU1037948541.HKD","LU1934455277.USD","LU1153585028.USD","LU1983260115.SGD","LU0266013472.USD","SG9999017495.SGD","IE000M9KFDE8.USD","LU0162691827.USD","LU0208291251.USD","LU0048584097.USD","LU0094547139.USD","IE0002270589.USD","IE00B4R5TH58.HKD","IE00BKPKM429.USD","VEEV","LU0965509010.AUD","LU0496365809.HKD","LU0708995401.HKD","LU0107464264.USD","FXH","LU0528227936.USD","LU2065170008.USD","LU1720051017.SGD","BK4504","LU2023251221.USD","LU1934455863.HKD","LU2362540622.SGD","HUM","IE00B19Z8X17.USD","LU1201861249.SGD","IE00BZ9MQY76.HKD","LU0238689110.USD","LU1670627923.USD","LU0149725797.USD","IE00B19Z9Z06.USD","LU0251132253.USD","LU0859254822.USD","LU0432979614.USD","BK4198","LU2491050071.SGD","LU2362541513.USD","LU1814569148.SGD","LU0820561909.HKD","LU1778281490.HKD","IE00BFTCPJ56.SGD","BK4588","IE00B19Z3B42.SGD","LU0130102774.USD","SGXZ99366536.SGD","LU1093756325.SGD","LU0128525929.USD","NBIX","LU0234572021.USD","SG9999014013.SGD","LU0348723411.USD","LU0882574055.USD","LU0187121727.USD","HALO","LU2065171402.SGD","LU1035773651.USD","EKG","LU0310800965.SGD","BK4196","LU0079474960.USD","LU0320765489.SGD","LU1496350502.SGD","LU0553294199.USD","BK4585","LU0203345920.USD","LU1914381329.SGD","LU0738911758.USD","LU2324357040.USD","SGXZ31699556.SGD","JDOC","LU0689472784.USD","LU0648000940.SGD","LU0211327993.USD","BK4534","LU1066051498.USD","DVA","HRTS","LU1066051225.USD","LU1791710400.SGD","LU1093756168.USD","GDOC","LU1551013425.SGD","LU0256863811.USD","LU0109391861.USD","SG9999014914.USD","LU2362541273.HKD","XLV","LU1066053197.SGD","LU2461242641.AUD","LU0320765059.SGD","LU2111349929.HKD","LU0477156797.USD","LU0708994859.HKD","LU2211815571.USD","LU0130518102.USD","LU1699723380.USD","LU0310800379.SGD","LU0158827781.USD","IE00B19Z3581.USD","LU0128525689.USD","IE0004445239.USD","LU0052756011.USD","LU0158827948.USD","SG9999001176.SGD","LU0211328371.USD","LU2357305700.SGD","LU2065169927.USD","LU0130103400.USD","LU1989764664.SGD","IE00B19Z9P08.USD","SGXZ57979304.SGD","LU2954938101.SGD","LU2552382132.HKD","SG9999018865.SGD","LU0912757837.SGD","LU1732800096.USD","LU2028103732.USD","BK4528","LU2087625088.SGD","LU1323610961.USD","LU0980610538.SGD","LU2089284900.SGD","LU0787776722.HKD","LU2244417387.USD","LU1023059063.AUD","UNH","IE00BJT1NW94.SGD","LU2491050154.USD","LU0353189680.USD","LU0154245673.USD","LU2133065610.SGD","LU2125154935.USD","BK4139","LU0390134368.USD","LU1551013342.USD","LU0795875086.SGD","SG9999014880.SGD","LU0053671581.USD","LU0130517989.USD","IE0002141913.USD","LU1854104046.USD","IE00B19Z9505.USD","SG9999014021.USD","LU0198837287.USD","SG9999001176.USD","LU0683600562.USD","LU1988902786.USD","LU0211326755.USD","LU0011850046.USD","SGXZ81514606.USD","TRUH","LU1989764748.USD","LU0965508806.USD","TMED","LU2279689827.SGD","LU1037948897.HKD","LU1061106388.HKD","LU1119994496.HKD","LU2361044949.HKD","LU0353189763.USD","IE00BZ1G4Q59.USD","LU0545039389.USD","LU0345770993.USD","IE00B894F039.SGD","LU1201861165.SGD","LU0053666078.USD","LU0058720904.USD","LU0170899867.USD","SG9999013999.USD","IE00B3T34201.USD","LU2360032135.SGD","IE00B4JS1V06.HKD","LU0097036916.USD","LU0456855351.SGD","LU1084165304.USD","SG9999014005.SGD","LU0820561818.USD","IE00B7KXQ091.USD","BK4007","IE0034235188.USD","LU2347655156.SGD","LU2999663052.SGD","LU1267930227.SGD","LU0477156953.USD","VHT","LU1670628061.USD","LU0211331839.USD","LU2242649171.HKD","LU0154245756.USD","LU1003077747.HKD","LU0965509101.SGD","LU2552382058.USD","BK4167","SG9999014906.USD","UNHG","LU1074936037.SGD","SGXZ51526630.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185214762","title":"异动解读｜达维塔保健盘中下跌5.01%，全年指引未上调及伯克希尔减持利空持续发酵","url":"https://stock-news.laohu8.com/highlight/detail?id=1185214762","media":"行情直击","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185214762?lang=zh_cn&edition=full","pubTime":"2026-08-07 03:36","pubTimestamp":1786045005,"startTime":"0","endTime":"0","summary":"8月7日，达维塔保健盘中下跌5.01%，报179.23美元/股，成交额1.92亿美元，延续此前跌势。消息面上，公司Q2调整后每股收益4.02美元超预期，但维持全年EPS指引14.10至15.20美元不变，中值14.65美元低于市场预期的14.88美元，被解读为下半年盈利增速放缓信号。同时，SEC文件显示伯克希尔·哈撒韦出售18.3万股公司股票，美银将目标价设定为170美元，低于当前股价，多重利空持续压制股价。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151436346","title":"异动解读｜达维塔保健盘中下跌17.34%，Q2业绩超预期但全年指引未上调叠加伯克希尔减持","url":"https://stock-news.laohu8.com/highlight/detail?id=1151436346","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151436346?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:34","pubTimestamp":1785940480,"startTime":"0","endTime":"0","summary":"8月5日，达维塔保健盘中下跌17.34%，报188.2美元/股，成交额2.92亿美元。然而公司维持全年调整后每股收益指引14.10至15.20美元不变，指引中值14.65美元低于市场一致预期的14.88美元。由于Q1和Q2连续大幅超预期，市场此前对上调全年指引抱有较高期待，指引维持不变被解读为隐含下半年盈利增速放缓信号。此外，SEC文件显示伯克希尔·哈撒韦近期出售18.3万股达维塔保健股票，美银将目标价调整至170美元，远低于当前股价，多重利空共振加剧抛压。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"达维塔保健盘中下跌17.34%，Q2业绩超预期但全年指引未上调叠加伯克希尔减持","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104962505","title":"异动解读｜达维塔保健盘前下跌5.94%，Q2业绩超预期但全年指引未上调叠加伯克希尔减持","url":"https://stock-news.laohu8.com/highlight/detail?id=1104962505","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1104962505?lang=zh_cn&edition=full","pubTime":"2026-08-05 18:12","pubTimestamp":1785924759,"startTime":"0","endTime":"0","summary":"8月5日，达维塔保健盘前下跌5.94%，报218.0美元/股。然而公司维持全年调整后每股收益指引14.10至15.20美元不变，指引中值14.65美元低于市场一致预期的14.88美元。由于Q1和Q2连续大幅超预期，市场此前对上调全年指引抱有较高期待，指引维持不变被解读为隐含下半年盈利增速放缓信号。此外，SEC文件显示伯克希尔·哈撒韦近期出售18.3万股达维塔保健股票，进一步加剧市场情绪压力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"达维塔保健盘前下跌5.94%，Q2业绩超预期但全年指引未上调叠加伯克希尔减持","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178423989","title":"异动解读｜达维塔保健夜盘下跌5.83%，Q2业绩超预期但全年指引未上调引发抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=1178423989","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178423989?lang=zh_cn&edition=full","pubTime":"2026-08-05 09:08","pubTimestamp":1785892114,"startTime":"0","endTime":"0","summary":"8月5日，达维塔保健夜盘下跌5.83%，报214.7美元/股。然而公司维持全年调整后每股收益指引14.10至15.20美元不变，指引中值14.65美元低于市场一致预期的14.88美元。由于Q1和Q2连续大幅超预期，市场此前对上调全年指引抱有较高期待，指引维持不变被解读为隐含下半年盈利增速放缓信号。此外，SEC文件显示伯克希尔·哈撒韦近期出售18.3万股达维塔保健股票，进一步加剧市场情绪压力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197792702","title":"伯克希尔·哈撒韦出售18.298万股达维塔保健股票，平均每股199.55美元，仍持有约2870万股——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1197792702","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197792702?lang=zh_cn&edition=full","pubTime":"2026-08-05 05:41","pubTimestamp":1785879668,"startTime":"0","endTime":"0","summary":"根据美国证券交易委员会（SEC）最新披露的文件显示，伯克希尔·哈撒韦公司已出售了18.298万股达维塔保健（DaVita HealthCare Partners）股票，平均每股售价为199.55美元。此次交易完成后，该公司仍持有约2870万股达维塔保健股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","DVA","BK4588","BK4585","BK4559"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.davita.com","stockEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0799},{"period":"3month","weight":0.0601},{"period":"6month","weight":-0.0193},{"period":"1year","weight":0.608},{"period":"ytd","weight":0.7148}],"compareEarnings":[{"period":"1week","weight":-0.0473},{"period":"1month","weight":-0.0592},{"period":"3month","weight":-0.0521},{"period":"6month","weight":-0.0063},{"period":"1year","weight":0.0818},{"period":"ytd","weight":0.0749}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"DaVita Inc.于1994年在特拉华州注册成立。达维塔保健 Inc.是一家领先的医疗保健供应商，专注于转变护理提供方式，以提高全球患者的生活质量。作为一家综合性肾脏护理提供者，达维塔保健拥有超过25年的经验，它提供的服务可在患者肾脏健康之旅的每个阶段为其提供支持——从减缓肾脏疾病的进展到促进移植。该公司经营透析中心，为家庭护理提供支持，并在医院和熟练的护理设施中提供服务。达维塔保健对创新和综合护理的承诺旨在改善结果，同时最大限度地降低成本，从而加强其作为值得信赖的提供者和合作伙伴在医疗保健领域的地位。","yearOnYearQuotes":[{"month":1,"riseRate":0.516129,"avgChangeRate":0.002865},{"month":2,"riseRate":0.483871,"avgChangeRate":-0.007883},{"month":3,"riseRate":0.548387,"avgChangeRate":0.019696},{"month":4,"riseRate":0.645161,"avgChangeRate":0.025606},{"month":5,"riseRate":0.612903,"avgChangeRate":0.026568},{"month":6,"riseRate":0.612903,"avgChangeRate":0.048539},{"month":7,"riseRate":0.548387,"avgChangeRate":-0.005018},{"month":8,"riseRate":0.419355,"avgChangeRate":-0.014304},{"month":9,"riseRate":0.548387,"avgChangeRate":0.016351},{"month":10,"riseRate":0.516129,"avgChangeRate":0.003822},{"month":11,"riseRate":0.625,"avgChangeRate":0.050558},{"month":12,"riseRate":0.580645,"avgChangeRate":0.040515}],"exchange":"NYSE","name":"达维塔保健","nameEN":"DaVita HealthCare Partners"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达维塔保健(DVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达维塔保健,DVA,达维塔保健股票,达维塔保健股票老虎,达维塔保健股票老虎国际,达维塔保健行情,达维塔保健股票行情,达维塔保健股价,达维塔保健股市,达维塔保健股票价格,达维塔保健股票交易,达维塔保健股票购买,达维塔保健股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达维塔保健(DVA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达维塔保健(DVA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}